It is therefore suggested that insulin mimetope-specific Foxp3+Treg induction may be better applied as a primary preventive approach or as a secondary vaccination strategy for non-diabetic children with longer autoimmunity that have successfully passed the critical period of autoimmune development without progression to overt disease (longterm autoimmunity without T1D). The gene discussed is INS; the disease is type 1 diabetes mellitus.